Palmitoylation regulates diverse aspects of neuronal protein trafficking and function. Here a global characterization of rat neural palmitoyl-proteomes identifies most of the known neural palmitoyl proteins-68 in total, plus more than 200 new palmitoyl-protein candidates, with further testing confirming palmitoylation for 21 of these candidates. The new palmitoyl proteins include neurotransmitter receptors, transporters, adhesion molecules, scaffolding proteins, as well as SNAREs and other vesicular trafficking proteins. Of particular interest is the finding of palmitoylation for a brain-specific Cdc42 splice variant. The palmitoylated Cdc42 isoform (Cdc42-palm) differs from the canonical, prenylated form (Cdc42-prenyl), both with regard to localization and function: Cdc42-palm concentrates in dendritic spines and has a special role in inducing these post-synaptic structures. Furthermore, assessing palmitoylation dynamics in drug-induced activity models identifies rapidly induced changes for Cdc42 as well as for other synaptic palmitoyl proteins, suggesting that palmitoylation may participate broadly in the activity-driven changes that shape synapse morphology and function.
Recent studies indicate an important role for palmitoylation in modulating neuronal protein trafficking and function 1 . This lipid modification-the attachment of the 16-carbon saturated fatty acid palmitate to cysteines by thioester linkage-functions in tethering proteins to membranes or in the sorting of proteins to particular lipid microdomains such as lipid rafts [1] [2] [3] [4] . Like phosphorylation, palmitoylation can be reversible, and can therefore dynamically regulate protein localization. A notable example of palmitoyl regulation in neurons is provided by the scaffolding molecule, postsynaptic density-95 (PSD-95, also known as Dlg4), the activity-directed palmitoylation-depalmitoylation of which regulates AMPA-type glutamate receptor retention at excitatory glutamatergic synapses 5 . Nonetheless, given the technical difficulties hindering palmitoylation analysis, coupled with a lack of palmitoylation consensus sequences for prediction, one expects that the scope of this modification's involvement at the synapse has been underestimated.
Neural palmitoyl-proteomes
Here we have applied acyl-biotinyl exchange (ABE) proteomic technology 5 , which purifies palmitoylated proteins from complex protein extracts, towards a comprehensive description of rat neural palmitoylproteomes. Use of this methodology in the yeast Saccharomyces cerevisiae tripled the number of known yeast palmitoyl proteins 6 . This method, based on the previously described ABE chemistry 7 , substitutes biotin for palmitoyl modifications through a sequence of three chemical steps: unmodified cysteine thiols are blocked with N-ethyl maleimide; palmitoylation thioester linkages are cleaved with hydroxylamine (HAM); and finally, newly-exposed cysteinyl thiols are marked with a thiol-specific biotinylation reagent. These biotinylated proteins are then affinity-purified with streptavidin-agarose and identified by multidimensional protein identification technology (MudPIT), which is a tandem mass spectrometry-based proteomic methodology 8 .
Proteins from cultured rat embryonic cortical neurons and purified synaptosomal membrane fractions (enriched for both pre-and postsynaptic membranes) extracted from whole adult rat brain tissues were used for this analysis. Application of ABE to cortical neurons purifies a wide spectrum of proteins ( Fig. 1a, 1 HAM) . A standard control that allows contaminant proteins to be distinguished involves processing protein extracts through a parallel protocol that omits the hydroxylamine cleavage step 6 (Fig. 1a, 2 HAM) . Four iterations of MudPIT analysis of samples with/without HAM identified 1,643 proteins, including many known palmitoyl proteins. Using spectral count-based quantification 9,10 , identified proteins were plotted by relative plus and minus HAM sample abundance ( Fig. 1b and Supplementary Methods). Proteins showing substantial abundances in both the plus and minus HAM samples are probably contaminant proteins, whereas proteins that cluster along the x axis with the known palmitoyl proteins ( Fig. 1b , red dots) represent the new palmitoylprotein candidates. Parallel ABE and MudPIT analysis of synaptosomal membrane fractions yielded a similar collection of known and candidate palmitoyl proteins that overlapped the neuronal collection considerably ( Fig. 1c , Supplementary Fig. 1 and Supplementary Tables  1-5 ).
The combined neuronal and synaptosomal MudPIT data sets were used to assign candidate palmitoyl proteins to a high-confidence group A and a lower-confidence group B. The 64 known palmitoyl proteins identified in these groupings were removed (50 from group A and 14 from group B; 4 known palmitoyl proteins were detected only at low significance levels; known palmitoyl proteins are listed and annotated in Supplementary Table 3 ). Also removed were proteins that were probably not palmitoylated but were detected by ABE because of their biochemical use of thioester linkages, a category that includes several ubiquitin conjugases/ligases, as well as enzymes using either lipoic acid or phosphopantetheine prostheses (Supplementary Table 6 ). The 113 group A candidates and 318 group B candidates that remain after these subtractions are listed and annotated in Supplementary Tables 4 and 5 , respectively (see Supplementary Methods for analysis details). For 21 of the new candidates, palmitoylation was subsequently confirmed using traditional [ 3 H]palmitate metabolic and/or ABE methodologies (Fig. 1d , e and Supplementary Fig. 2 ).
Many of the new candidate palmitoyl proteins (Box 1 and Supplementary Fig. 1 ), are hydrophilic proteins, with palmitoylation probably functioning for membrane tethering. However, most of the candidates are predicted transmembrane proteins, in which palmitoylation may provide targeting to specialized membrane microdomains, or perhaps function structurally, modifying the protein's transmembrane architecture. Notable highlights of our list include AKAP79/150 (also known as Akap5) and gephyrin (Gphn) scaffolding proteins, numerous ion channels, voltage-gated Na channels, as well as several transporters for neurotransmitter re-uptake (Box 1). Adding to the list of ionotropic neurotransmitter receptor subunits recently found to be palmitoylated 1, 11 , our method identifies the NMDA receptor subunits NR2A (Grin2a) and NR2B (Grin2b), as well as the serotonin receptor subunit 5HT-3C (Htr3c). Numerous SNARE proteins also are prominently detected, including six different syntaxins and three VAMPs. Other important proteins identified include those involved in regulation of growth cone dynamics (semaphorin-4D and latrophilin 1), and synaptic adhesion (protocadherins Pcdh1, 8, 9, 10 and 17, the d-catenin Ctnnd2, synCAM4 (also known as Cadm4 and Necl4) and ephrin receptors).
A palmitoylated Cdc42 splice variant
Our strong proteomic identification of Cdc42 as a candidate palmitoyl protein was intriguing. Like other Rho GTPases, Cdc42 uses actin cytoskeletal regulation to reshape cellular morphology inducing filipodia in many cell types, and in neurons it has been implicated in inducing axon/dendrite outgrowth, dendritic arborization, and spine formation [12] [13] [14] [15] [16] . Although Cdc42 is well known to be prenylated 17 , it has not been shown to be palmitoylated. Furthermore, Cdc42 differs from dually palmitoylated-prenylated G proteins such as H-Ras and N-Ras, in that it lacks cysteines proximal to its carboxy-terminal CaaX prenylation motif (in which C is Cys, a is an aliphatic amino acid, and X is a variety of amino acids) that might act as palmitoyl acceptors. However, a second Cdc42 splice variant has been reported that exchanges in an alternative C-terminal exon, which replaces the prenylation motif with a new C-terminal domain that terminates with the tetrapeptide sequence Cys-Cys-Ile-Phe 18 (Fig. 2a ). Using metabolic [ 3 H]palmitate labelling, we find that this Cdc42 splice variant (isoform 2) is palmitoylated, whereas the canonical form is not ( Fig. 2b ). Furthermore, introduction of the Cys-CysRSer-Ser mutation ( Fig. 2a ) eliminates this palmitoylation, implicating these cysteines as the probable palmitoyl acceptors. Notably, although the canonical, prenylated Cdc42 isoform (Cdc42-prenyl) is expressed in all tissues, the variant, palmitoylated form (Cdc42-palm) is expressed only in the brain 18 (Fig. 2c ). Quantitative messenger RNA analysis finds the two forms to be expressed at roughly similar levels in brain and neuronal culture ( Supplementary Fig. 3 ).
Cdc42-palm and dendritic spines
To assess the implications of this neuron-specific Cdc42 palmitoylation, we first examined the effects on localization. The two isoforms show distinct dendritic localizations: whereas Cdc42-prenyl distributes throughout the dendrite to dendritic spine and shaft alike, Cdc42-palm is found to be more heavily concentrated in dendritic spines, a distribution that is abolished by the introduction of the palmitoylation-defective Cys-CysRSer-Ser mutation (Fig. 3a) . Consistent with this, a neuronal membrane fractionation analysis finds that the two isoforms also show distinctive patterns of fractionation ( Supplementary Fig. 4 ). Cdc42 activity is known to modulate signalling pathways and plasticity-related mechanisms that regulate spine morphology [12] [13] [14] [15] [16] [19] [20] [21] . To determine whether palmitoylation is involved in regulating Cdc42 function at the synapse, we contrasted the effects of the Cdc42 splice variants on spine induction. Constructs expressing constitutively-active (CA) Gly12Val mutant forms of Cdc42(CA)-palm and Cdc42(CA)-prenyl were transfected into developing cultured hippocampal neurons at 7 days in vitro (DIV 7), with changes in spine number analysed at DIV 14 (Fig. 3b ). Although Cdc42(CA)-prenyl is clearly active in this assay showing a significant induction of dendritic spines, a substantially more robust spine induction is seen for Cdc42(CA)-palm ( Fig. 3b ). Mutation of the two palmitoyl-accepting cysteines (Cdc42(CA)Cys-CysRSer-Ser) abolishes this induction. Similarly, pre-treatment with the general palmitoylation inhibitor 2-bromopalmitate (2BP) blocked spine induction by Cdc42(CA)-palm, but not by and -HAM (y coordinate) spectral counts. The 58 proteins that were known to be palmitoylated before this analysis are shown as red dots. New candidate palmitoyl proteins co-cluster along the x axis (region indicated) with the known palmitoyl proteins. c, Overlapping identification of known palmitoyl proteins, by the neuronal and synaptosomal proteomic analyses. d, Summary of palmitoylation testing. Results are summarized for the 21 candidate proteins that were individually tested for palmitoylation either by [ 3 H]palmitate metabolic labelling or by ABE methodologies (see Supplementary Fig. 2 ). ND, not determined. e, Verification of palmitoylation for selected palmitoyl protein (PP) candidates. Proteins, ABE-purified from cultured neurons exactly as for proteomic analysis, both in the presence (1) and absence (2) of HAM, were analysed by western blotting using the indicated specific antibodies. Palmitoylated proteins are expected to show HAM-dependent detection. As a control, a portion of the starting protein sample (before ABE purification) was also screened (total).
Cdc42(CA)-prenyl. Replication of this analysis in COS-7 cells yielded similar results: a substantially more robust filopodia induction was seen with Cdc42(CA)-palm, with the induction abolished by the Cys-CysRSer-Sermutation and severely diminished by 2BP treatment ( Supplementary Fig. 5 ).
To examine the role of endogenously expressed Cdc42, plasmidbased short interfering RNAs (siRNAs) targeting sequences either common or unique to the two Cdc42 isoforms ( Supplementary  Fig. 6 ) were transfected into DIV 9 neurons, with spine density analysed on DIV 14 (Fig. 3c ). Consistent with a recent siRNA analysis 21 , a construct targeting sequences common to the two isoforms significantly inhibited spine formation (Pan siRNA; Fig. 3c ). In terms of individual isoform contributions, a knockdown of Cdc42-prenyl expression showed no discernible effect on spine induction, being indistinguishable from both empty vector or scrambled siRNA controls. In contrast, the Cdc42-palm knockdowns, using either of our two Cdc42-palm-targeted siRNA plasmids, yielded highly significant spine number reductions. Thus, the Cdc42-palm isoform is required for spine induction-a key step of synaptogenesis.
We have used the same siRNA analysis to examine Cdc42 isoform roles in the induction of dendritic filopodia. These filopodia are thought to be spine precursors, extending out from the dendrite to explore the local environment for potential pre-synaptic connections 22 . As we found for spines, filopodia also uniquely rely on the palmitoylated Cdc42 isoform: filopodia numbers are significantly knocked down by the Cdc42-palm-targeted siRNA, but not by the Cdc42-prenyl siRNA ( Supplementary Fig. 7c ). As a further siRNA-specificity control, we have demonstrated that an overproduced Cdc42-palm, having silent changes in the siRNA target sequence making it siRNA-resistant, is able to fully rescue the filopodia knockdown ( Supplementary  Fig. 7a-c) . In contrast, Cdc42-prenyl affords only a partial rescue, indicating that Cdc42-prenyl, when similarly overproduced, substitutes only poorly for depleted Cdc42-palm function. Thus, as for spines, Cdc42-palm plays the predominant role in the induction of dendritic filopodia as well.
Regulatable synaptic palmitoylation
The functional differences distinguishing the two Cdc42 isoforms must ultimately redound to their different lipid modifications, perhaps reflecting the differential membrane microdomain affinity of the two lipids; palmitoylated proteins typically show increased segregation into raft-like domains 3 , which are known to be enriched in dendritic spines 23 . The two forms also differ with regard to their regulatory potential, with Cdc42-palm potentially controllable by reversible palmitoylation. To examine palmitoyl turnover, a panel of neuronal palmitoyl proteins, including Cdc42, was assessed for palmitate loss after a 5-h period of 2BP-instigated palmitoylation blockade in cultured neurons. In the presence of 2BP, proteins that undergo rapid, constitutive palmitoyl recycling should fail to be repalmitoylated and should therefore be lost from the ABE-purified palmitoyl proteome. Providing proof of principle, we see that PSD-95, which is known to undergo rapid palmitoyl cycling 5 , is indeed largely lost from the 2BPtreated palmitoyl proteome (Fig. 4a, b) . The unaltered PSD-95 levels detected in the starting, unpurified protein extracts (Fig. 4a , total panels), indicates this to be palmitoyl turnover, not protein turnover. Significant palmitoyl turnovers were also seen for Cdc42, as well as for two other G proteins, H/N-Ras and Rho-B (Fig. 4a, b) . In contrast, the 2BP treatment had little or no effect on other proteins, namely Snap25,
Box 1 | New palmitoyl-protein candidates
The proteins with strong proteomic support for palmitoylation are listed by functional category. In the list below, proteins with confirmed palmitoylation (Fig. 1e ) are indicated by asterisks. For more complete, annotated listings of both known and newly identified candidate palmitoyl proteins see Supplementary Fig. 1 and Supplementary Tables 3-6 .
Receptors and channels
The receptors and channels include NR2A* and NR2B*, the voltagegated Na-channel a subunits Scn1a, Scn2a1, Scn3a and Scn9a, the tweety-like Cl-channels Ttyh1 and Ttyh3, the prostaglandin receptor regulator Ptgfrn, Htr3c and the Ca-activated K-channel Kcnma1.
Scaffolding proteins
Scaffolding proteins include AKAP79/150*, the PSD-95-associated protein Dlgap2 and Gphn (gephyrin)*.
Membrane trafficking
Membrane trafficking proteins include numerous SNARE proteins, the syntaxins Stx1a*, Stx1b2*, Stx6*, Stx7, Stx8, Stx12* and Stx19*, and the VAMPs Vamp1, Vamp4 and Vamp7. Other trafficking proteins include Scamp1*, Scamp3, Scamp5*, the Rab GTPases Rab1b, Rab3, Rab5, Rab7, Rab10, Rab14, the lysosomal sorting receptor Sort1, the reticulons Rtn1* and Rtn3 and the proteolipid-protein (PLP)-like Gpm6a (M6a)*.
Cell adhesion
The cell adhesion proteins include Mcam, the ephrin receptors Epha5, Epha3 and Ephb2, the ephrin ligand Efnb3, SynCAM4*, Igsf8 (PGRL; EWI-2), the protocadherins Pcdh1*, Pcdh8, Pcdh9, Pcdh10, Pcdh17 and Pcdhac2, Ctnnd2 (d-catenin-2)*, Cxadr (coxsackie and adenovirus receptor), Astn1 (astrotactin-1), Cntn1 (contactin-1), Jam3 (junctional CAM-3), Pkp4 (plakophilin-4), Sema4d (semaphorin-4D), Lphn1 (latrophilin-1), Plxnb2 (plexin-B2) and Neo1 (neogenin-1).
Myelin-associated
The myelin-associated proteins include Mbp (myelin basic protein and Golli-MBP), Mobp (myelin-associated oligodendrocyte basic protein) and Mog (myelin oligodendrocyte glycoprotein).
Transporters
Transporter proteins include the glutamate transporters Slc1a1, Slc1a2 and Slc1a3 (GluT-1)*, the vesicular GABA transporters Slc6a1 and Slc32a1, the Ca transporters Atp2b1, Atp2b3 and Atp2c1, the Na/Ca exchangers Slc8a1 and Slc8a2, the amino acid transporter Slc3a2 and the choline transporter Slc4a2.
GTPases and signalling proteins
GTPases and signalling proteins include Cdc42*, Rac1, Rras, Rras2, Rala, Ralb, septins Sept3, Sept6 and Sept8, Ga-interacting Gprin1* and Gprin3, the Rho-GDIa Arhgdia, the sprouty-related proteins Spred1 and Spred2, adenylyl cyclases Adcy1, Adcy5, Adcy6 and Adcy9 (palmitoylation has been reported for an adenylyl cyclase previously; however, the isoform identity of the palmitoylated cyclase was not determined 32 ), the inositol phosphatase Inpp5a, the FYVE-motif phosphoinositide-binding protein Zfyve28 and the cAMP/cGMP dual phosphodiesterase Pde10a.
Cytoskeletal proteins
Cytoskeletal proteins include the actin-binding protein Ablim2 and the dynein intermediate chain Dync1i1*.
Chaperones
Chaperone proteins include calnexin* and the peptidyl-prolyl isomerase Ppib.
Metabolism
Proteins involved in metabolism include the palmitoyl transferase Zdhhc5, Agpat1 (involved in lipid biosynthesis), the calpain Capn5, the gamma-glutamyl transpeptidase Ggt7, the cytochrome b5 reductase Cyb5r3 and the mercaptopyruvate sulphotransferase Mpst.
Mitochondrial
Mitochondrial proteins include Cox6c (which acts in the respiratory chain) and the outer membrane porins Vdac1, Vdac2 and Vdac3. synaptotagmin 1 (Syt1), Scamp1 and the glutamate transporter GluT-1 (Slc1a3), indicating that the palmitoyl modifications of these proteins are relatively stable under basal conditions; we note that these proteins showing stable palmitoylation are largely presynaptic. The differential palmitoyl-modification stabilities for Cdc42, Snap25, Stx1b and Syt1 have been confirmed by [ 3 H]palmitate labelling pulse-chase analysis ( Supplementary Fig. 8 ). We also find that 2BP treatment results in a notable inhibition of endogenous neuronal Cdc42 activity ( Supplementary Fig. 9 ). In addition to affecting Cdc42 palmitoylation, 2BP may also affect upstream components in this pathway, thus potentially affecting Cdc42 activity indirectly.
Regulated palmitoylation may have a role in modulating the cytoskeletal changes that are associated with activity-driven synapse remodelling 24 . To gain insights into how palmitoyl regulation might couple to synaptic activity, we have tracked our test panel of neuronal palmitoyl proteins for rapidly-induced palmitoylation changes in response to a 5-min treatment with 50 mM glutamate-a treatment that modulates synaptic activity and spine morphology through the activation of synaptic and extrasynaptic glutamate receptors [25] [26] [27] [28] . The effects on palmitoylation are surprisingly broad, with proteins showing both increases and decreases in palmitoylation ( Fig. 4c and Supplementary Fig. 10a ). The results for Cdc42 are particularly notable, with dendritic localizations for Cdc42-palm and Cdc42-prenyl. Hippocampal neurons transfected with the indicated GFP-Cdc42 constructs on DIV 7 were analysed on DIV 14 using anti-GFP immunofluorescence. Relative distribution to dendritic shaft versus spine was analysed with the spine targeting index (STI; see Supplementary Methods ). An STI of 1 indicates passive distribution, .1 indicates accumulation of the GFP-Cdc42 construct within spines; n 5 10 cells. b, Differential spine induction activity for constitutively-active (CA; Gly12Val mutation) versions of the GFP-Cdc42 constructs were co-transfected with a DsRed expression plasmid into hippocampal neurons on DIV 7, with spine density assessed on DIV 14. Parallel cultures were treated with 100 mM 2BP for 5 h on DIV 14 to assess effects of palmitoylation inhibition; n 5 14-24 cells. The inhibition of spine induction by Cdc42(CA)Cys-CysRSer-Ser relative to the vector control is significant, suggesting a dominant-negative action for this mislocalized mutant. c, The Cdc42-palm isoform is required for spine development. pSUPER/GFP-based siRNA expression plasmids, targeting sequences specific to either Cdc42-prenyl or Cdc42-palm mRNAs, were transfected into hippocampal neurons on DIV 9, with spine densities assessed on DIV 14. Results for six different knockdown constructs are reported: a prenyl siRNA targeting the Cdc42-prenyl isoform (41 cells analysed); two different palm siRNAs (palm 1 and 2, 25 and 10 cells, respectively) targeting the Cdc42-palm isoform; a Pan siRNA targeting a sequence common to both isoforms (12 cells); a scrambled siRNA of a scrambling of a Pan siRNA target sequences (31 cells); and an empty pSUPER/GFP vector (56 cells). COS-7 cell testing of knockdown efficacy showed that the four knockdown constructs reduced expression of their target isoform by 65-70% ( Supplementary Fig. 6 ). *P , 0.05, **P , 0.01, ***P , 0.001; scale bars, 5 mm; error bars, mean and s.e.m. a, C-terminal amino acid sequences of the two alternatively-spliced Cdc42 isoforms. Isoform 1 is the previously characterized prenylated form of Cdc42 (Cdc42-prenyl), whereas isoform-2 is the variant form, shown in panel b to be palmitoylated (Cdc42-palm). The Cys-CysRSer-Ser mutation removes the two putative palmitoyl-accepting cysteines from Cdc42-palm. b, Cdc42 isoform-2 (Cdc42-palm) is palmitoylated. COS-7 cells transfected by the indicated GFP-Cdc42 constructs were metabolically labelled with [ 3 H]palmitic acid. GFP-Cdc42 proteins were immunoprecipitated then subjected either to autoradiography to assess palmitate incorporation, or to western analysis (WB). c, Cdc42-palm expression is limited to the brain. Tissue specific expression of the two Cdc42 isoforms was analysed by RT-PCR. RNA was analysed from the indicated organs, brain regions (cerebellum (CB); hippocampus (HIP); cortex (CX)), as well as from developing cultured embryonic cortical neurons.
glutamate inducing rapid depalmitoylation. Correlated with this depalmitoylation, glutamate also results in a rapid dislocation of Cdc42 from dendritic spines ( Supplementary Fig. 11 ). These rapidly induced changes to Cdc42 palmitoylation and localization correlate with, and may contribute to, the rapid spine collapse that accompanies such high-level glutamate treatments in neurons 29 . Thus, the concentration of Cdc42 in spines can be rapidly modified by neuronal activity in a palmitoylation-dependent manner, with dynamic Cdc42 palmitoylation perhaps serving to rapidly regulate synapse architecture in response to changing neuronal activity.
To explore the role of palmitoylation modulation in the in vivo brain, we have monitored palmitoylation changes in response to treatment with kainic acid-a drug that enhances neuronal excitability, inducing synchronous neuronal firing, ultimately leading to seizure-like activity 30, 31 . Animals were injected with 10 mg kg 21 kainic acid and tissues were collected within 30 min of seizure activity onset. As with the glutamate-treated neurons (Fig. 4c ), we find that surprisingly broad changes in palmitoylation are induced; in this case, however, increased palmitoylation is the predominant change ( Fig. 4d and Supplementary  Fig. 10b ). These palmitoylation increases suggest actions on pools of non-palmitoylated proteins, with palmitoylation perhaps acting to recruit proteins to synapses. Thus, in brain, as in cultured neurons, changes in neuronal activity result in palmitoylation changes that are rapidly and broadly induced, indicating modulation of palmitoylation to be an early event elicited by changes in neuronal firing. Our proteomic analysis has greatly expanded the neuronal purview of palmitoylation, highlighting a broad role in regulating synaptic function.
METHODS SUMMARY
Palmitoylation analysis relied in a large part on the ABE purification of palmitoyl proteins en masse from whole rat brain, from purified rat synaptosomes, or from cultured embryonic rat neurons. This procedure, which starts with denatured protein extracts, is an in vitro chemical exchange of biotin for thioester-linked acyl modifications, with the resulting biotinylated protein being affinity-purified using streptavidin-agarose. Subjecting the purified proteins to MudPIT mass spectral analysis identified the contingent palmitoyl proteins. These purified palmitoyl-proteomic samples were also used to follow individual protein palmitoylation levels in drug-induced neural activity mechanisms, for example, analysing changes after a 5-min treatment of neuronal cultures with 50 mM glutamate or the induced changes in the post-seizure brain (kainic acidinduced). For such analysis, purified palmitoyl-proteomic samples from the treated and control conditions were immunoblotted with panels of antibodies specific to individual neuronal palmitoyl proteins; proteins with increased or decreased palmitoylation showed corresponding increased or decreased abundance levels within the purified proteomic samples. Representations within the purified samples were normalized to levels in starting, total protein extracts, eliminating the potential contributions from changes in protein expression or turnover. The localization and function of the two Cdc42 isoforms were assessed in cultured embryonic rat hippocampal neuronal cells transfected with plasmids expressing amino-terminally enhanced green fluorescent protein (EGFP)-tagged versions of the two Cdc42 isoforms (wild-type and mutant forms) or for the knockdown analysis, isoform-specific siRNAs expressed from a plasmid also coexpressing a cytosolic GFP marker. Transfected cells, identified by GFP immunodetection, were analysed for Cdc42 localization and morphology, for example, the number of dendritic filopodia or spines. models. ABE and western analysis were used to follow palmitoylation changes within selected panels of neuronal palmitoyl proteins in response to three treatment regimens: 5-h treatment of cortical neurons with 100 mM 2BP to assess constitutive palmitoyl turnover (a, b), 5-min treatment of cortical neurons with a 50 mM glutamate excitatory stimulus (c), and after kainic-acid-induced seizures (10 mg kg 21 kainic acid injected intraperitoneally with brain collected within 30 min of the onset of seizure activity) (d). a, Example western blots are shown for the 2BP treatment regimen. Total palmitoyl proteins, ABE-purified from the 2BP-treated anduntreated neuronal cultures were blotted with the indicated specific antibodies. To control for 2BP effects on test protein expression levels, the initial unpurified protein extracts were also blotted (total). Western blot data for glutamate-and seizure-induced changes are provided in Supplementary Fig. 10 . b-d, Quantification of the palmitoylation changes induced by the three treatment protocols. Protein levels measured from the purified palmitoyl-protein samples (palm) were normalized to levels measured from the corresponding unpurified extracts (total). See Supplementary Methods for details. Data are presented from three independent experiments as means and s.e.m.; *P , 0.05, **P , 0.01, ***P , 0.001. Note, some antibodies detect several paralogues and/or isoforms: the Cdc42 antibody recognizes both Cdc42-palm and Cdc42prenyl isoforms; the Ras antibody recognizes H-, N-and K-Ras (only H-and N-Ras are palmitoylated); the Rho A/B antibody recognizes both Rho A and Rho B (only Rho B is palmitoylated).
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